Estimating HIV incidence in the Akwa Ibom AIDS indicator survey (AKAIS), Nigeria using the limiting antigen avidity recency assay.


Journal

Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566

Informations de publication

Date de publication:
02 2021
Historique:
received: 06 05 2020
revised: 31 12 2020
accepted: 13 01 2021
entrez: 23 2 2021
pubmed: 24 2 2021
medline: 18 9 2021
Statut: ppublish

Résumé

HIV incidence estimates are important to characterize the status of an epidemic, identify locations and populations at high risk and to guide and evaluate HIV prevention interventions. We used the limiting antigen avidity assay (LAg) as part of a recent infection testing algorithm to estimate HIV incidence in the Akwa Ibom AIDS Indicator Survey (AKAIS), Nigeria. In 2017, AKAIS, a cross-sectional population-based study was conducted at the household (HH) level in 31 local government areas (LGAs) of Akwa Ibom state. Of the 8963 participants aged ≥15 years who were administered questionnaires for demographic and behavioural data, 8306 consented to HIV rapid testing. Whole-blood specimens were collected from 394 preliminary HIV-seropositive individuals for CD4+ cell count determination and plasma storage. Samples were shipped to a central quality laboratory for HIV confirmatory testing and viral load determination. A total of 370 HIV-positive specimens were tested for the recent HIV infection using the LAg assay. Of the 8306 consenting adults, the HIV prevalence was 4.8%. Of the 370 HIV-positive samples tested for HIV recency, the median age was 35 years, 48.8% had CD4+ cell count >500/mm The finding of the high HIV incidence among the 15 to 49-year age group calls for renewed and innovative efforts to prevent HIV infection among young adults in Akwa Ibom state.

Identifiants

pubmed: 33619853
doi: 10.1002/jia2.25669
pmc: PMC7900440
doi:

Substances chimiques

Anti-HIV Agents 0
HIV Antibodies 0
HIV Antigens 0

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e25669

Subventions

Organisme : PEPFAR
Pays : United States

Informations de copyright

© 2021 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

Références

PLoS One. 2012;7(3):e33328
pubmed: 22479384
PLoS One. 2018 Oct 24;13(10):e0204840
pubmed: 30356287
PLoS One. 2012;7(9):e44377
pubmed: 22984497
PLoS One. 2020 Jun 17;15(6):e0234079
pubmed: 32555584
World Health Organ Tech Rep Ser. 2006;938:15-41; discussion 317-41
pubmed: 16921916
Epidemiol Rev. 2010;32:26-37
pubmed: 20203104
J Health Popul Nutr. 2007 Jun;25(2):146-57
pubmed: 17985816
PLoS One. 2014 Jan 27;9(1):e84979
pubmed: 24475035
PLoS One. 2013 May 22;8(5):e64201
pubmed: 23717568
AIDS Res Hum Retroviruses. 2017 Nov;33(11):1114-1116
pubmed: 28670965
AIDS. 2010 Nov 27;24(18):2763-71
pubmed: 20975514
PLoS Med. 2011 Jun;8(6):e1001045
pubmed: 21731474
Stud Fam Plann. 2004 Dec;35(4):223-35
pubmed: 15628781
J HIV AIDS Surveill Epidemiol. 2010 Jan 1;2(1):1-14
pubmed: 21743821
PLoS One. 2018 Sep 13;13(9):e0203638
pubmed: 30212513
J Int AIDS Soc. 2016 Jun 30;19(1):20917
pubmed: 27370169
J Math Biol. 2010 May;60(5):687-710
pubmed: 19633851
AIDS. 2014 Nov;28 Suppl 4:S461-7
pubmed: 25406749
PLoS One. 2015 Feb 24;10(2):e0114947
pubmed: 25710171
AIDS. 2014 May 15;28(8):1227-32
pubmed: 24513567
S Afr Med J. 2007 Mar;97(3):194-9
pubmed: 17440667

Auteurs

Olubunmi R Negedu-Momoh (OR)

Laboratory services and HSS Department, FHI 360, Abuja, Nigeria.
Global Public Health Department, IHR Strengthening Programme, Public Health England, Abuja, Nigeria.

Oluseyi Balogun (O)

Laboratory services and HSS Department, FHI 360, Abuja, Nigeria.

Ibrahim Dafa (I)

Laboratory services and HSS Department, FHI 360, Abuja, Nigeria.

Akan Etuk (A)

Laboratory Services Department, University of Uyo Teaching Hospital, Uyo, Nigeria.

Edward Adekola Oladele (EA)

Prevention, Care and Treatment Department, FHI 360, Abuja, Nigeria.

Oluwasanmi Adedokun (O)

Monitoring and Evaluation Department, FHI 360, Abuja, Nigeria.

Ezekiel James (E)

Office of the HIV/AIDS and TB, United States Agency for International Development (USAID), Abuja, Nigeria.

Satish R Pandey (SR)

Program Management Department, FHI 360, Abuja, Nigeria.

Hadiza Khamofu (H)

Prevention, Care and Treatment Department, FHI 360, Abuja, Nigeria.

Titi Badru (T)

Monitoring and Evaluation Department, FHI 360, Abuja, Nigeria.

Janet Robinson (J)

Infectious Diseases and Health Systems, FHI 360, Durham, NC, USA.

Timothy D Mastro (TD)

FHI 360, Durham, NC, USA.

Kwasi Torpey (K)

College of Health Sciences, University of Ghana, Accra, Ghana.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH